Vivace Therapeutics, Inc.

About Vivace Therapeutics, Inc.

Vivace Therapeutics is an oncology-focused small molecule drug discovery and development company based in the San Francisco Bay Area. The company is dedicated to turning novel biology into first-in-class cancer therapeutics, adopting a capital-efficient approach to bring innovative therapies to patients. Driven by passion and conviction, Vivace aims to help people fight cancer and live life to the fullest with a vision to generate exceptional value for shareholders and patients through smart business strategies and strong scientific advancements.

Products & Services

VT3989:A first-in-class YAP/TEAD inhibitor targeting the Hippo-YAP pathway, currently in Phase 1 clinical trials for advanced solid tumors, particularly mesothelioma and tumors with NF2 mutations.

YAP-TEAD Transcription Activity Inhibitors:Novel small-molecule medicines targeting the Hippo-YAP pathway to regulate cell proliferation, programmed cell death, and cell migration, with potential applications in various cancers and non-oncology indications like fibrotic disease.

Specialties

Small molecule drug discovery and development Hippo-YAP pathway targeting First-in-class cancer therapeutics YAP-TEAD transcription activity inhibitors

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series D T: - FT: Series D	A: 35000000 MR: - FA: $35 million FAN: 35000000	D: 2025-03-12 FD: 2025-03-12	3 investors

Series D Latest

2025-03-12

$35.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Edward Hu

MBA

T

Tim Shannon

General Partner

S

Sofie Qiao

President and Chief Executive Officer

N

Norman Zhou

Managing Director

J

Jake Simson

Partner

N

Neelesh Sharma

Chief Medical Officer

View 32 more team members with Pro

Unlock Full Team Directory

Recent News